Author:
Shinomiya Shun,Kaira Kyoichi,Yamaguchi Ou,Ishikawa Keitaro,Kagamu Hiroshi
Publisher
Ovid Technologies (Wolters Kluwer Health)
Reference7 articles.
1. Osimertinib or platinum-pemetrexed in EGFR T790M-positive lung cancer;Mok;N Engl J Med,2017
2. Cardiac dysfunction caused by osimertinib;Oyakawa;J Thorac Oncol,2017
3. Congestive heart failure during osimertinib treatment for epidermal growth factor receptor (EGFR)-mutant non-small cell lung cancer (NSCLC);Watanabe;Intern Med,2017
4. Osimertinib-induced cardiac dysfunction in EGFR-mutated lung cancer: a case series of five patients;Reale;Am J Cancer Case Reports,2018
5. Osimertinib induced cardiotoxicity: a retrospective review of the FDA adverse events reporting system (FAERS);Anad;JACC Cardiooncology,2019
Cited by
13 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献